Timothy Carlon, MD

Medical Education
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Residency
Integrated Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY – Chief Resident
Board Certification
American Board of Radiology
Subspecialties
Dr. Carlon is a board-certified vascular and interventional radiologist providing comprehensive, minimally invasive care across a broad range of conditions. He works closely with patients and referring physicians to develop individualized treatment plans grounded in the latest evidence and tailored to each patient’s goals.
His clinical interests include:
- Peripheral arterial disease: Angioplasty, stenting, atherectomy, and limb-salvage interventions for patients with advanced disease and limited treatment options
- Venous thromboembolism: Treatment of acute and chronic deep vein thrombosis (DVT), pulmonary embolism, and venous compression syndromes; IVC filter placement and removal
- Men’s health: Prostate artery embolization for enlarged prostate (BPH) and varicocele embolization
- Women’s health: Uterine fibroid embolization and treatment of pelvic venous disease
- Interventional oncology: Chemoembolization, yttrium-90 radioembolization, portal vein embolization, and percutaneous tumor ablation
- Musculoskeletal intervention: Minimally invasive treatments for osteoarthritis, including genicular artery embolization, and vertebral compression fractures, including kyphoplasty and vertebroplasty
Dr. Carlon has authored peer-reviewed publications on the treatment of pulmonary embolism, deep vein thrombosis, vertebral compression fractures, and hemodialysis access.
He completed integrated interventional radiology and diagnostic radiology residency training at the Icahn School of Medicine at Mount Sinai in New York, serving as chief resident in his final year. He earned his medical degree from the University of Pennsylvania’s Perelman School of Medicine, where he was elected to the Alpha Omega Alpha (AOA) Honor Medical Society, and his MBA from the Wharton School. Prior to medical school, he studied biomedical engineering at Duke University, graduating summa cum laude.
